The latest price target for Privia Health Gr (NASDAQ:PRVA) was reported by Macquarie on December 16, 2024. The analyst firm set a price target for $25.00 expecting PRVA to rise to within 12 months (a possible 28.40% upside). 22 analyst firms have reported ratings in the last year.

The latest analyst rating for Privia Health Gr (NASDAQ:PRVA) was provided by Macquarie, and Privia Health Gr initiated their outperform rating.

The last upgrade for Privia Health Group Inc happened on February 22, 2022 when Cowen & Co. raised their price target to $35. Cowen & Co. previously had a market perform for Privia Health Group Inc.

The last downgrade for Privia Health Group Inc happened on February 22, 2024 when B of A Securities changed their price target from $27 to $21 for Privia Health Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Privia Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Privia Health Gr was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest Privia Health Gr (PRVA) rating was a initiated with a price target of $0.00 to $25.00. The current price Privia Health Gr (PRVA) is trading at is $19.47, which is within the analyst’s predicted range.